Search Results - "Bello, Alfonso E"

Refine Results
  1. 1

    Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen by Ekman, Evan F, Gimbel, Joseph S, Bello, Alfonso E, Smith, Michael D, Keller, David S, Annis, Karen M, Brown, Mark T, West, Christine R, Verburg, Kenneth M

    Published in Journal of rheumatology (01-11-2014)
    “…Two studies evaluated efficacy and safety of tanezumab versus naproxen for treatment of knee or hip osteoarthritis (OA). Randomized controlled studies…”
    Get full text
    Journal Article
  2. 2

    Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study by Singh, Gurkirpal, Fort, John G, Goldstein, Jay L, Levy, Roger A, Hanrahan, Patrick S, Bello, Alfonso E, Andrade-Ortega, Lilia, Wallemark, Carl, Agrawal, Naurang M, Eisen, Glenn M, Stenson, William F, Triadafilopoulos, George

    Published in The American journal of medicine (01-03-2006)
    “…To evaluate the efficacy and upper gastrointestinal (UGI) safety of celecoxib, compared with nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs), among…”
    Get more information
    Journal Article
  3. 3

    Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications by Bello, Alfonso E., Holt, Robert J.

    Published in Drug safety (01-11-2014)
    “…In February 2014, the US Food and Drug Administration (FDA) convened an advisory committee meeting to discuss the accumulated data relating to the…”
    Get full text
    Journal Article
  4. 4

    Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders:a review of the literature by Bello, Alfonso E., Oesser, Steffen

    Published in Current medical research and opinion (01-11-2006)
    “…ABSTRACT Background: There is a need for an effective treatment for the millions of people in the United States with osteoarthritis (OA), a degenerative joint…”
    Get full text
    Journal Article
  5. 5

    Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers by Laine, Loren, Kivitz, Alan J, Bello, Alfonso E, Grahn, Amy Y, Schiff, Michael H, Taha, Ali S

    Published in The American journal of gastroenterology (01-03-2012)
    “…We performed two 24-week double-blind trials (REDUCE-1 and -2 (Registration Endoscopic Studies to Determine Ulcer Formation of HZT-501 Compared with Ibuprofen:…”
    Get full text
    Journal Article
  6. 6

    Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis by Bello, Alfonso E, Perkins, Elizabeth L, Jay, Randy, Efthimiou, Petros

    Published in Open Access Rheumatology (01-01-2017)
    “…Methotrexate (MTX) remains the cornerstone therapy for patients with rheumatoid arthritis (RA), with well-established safety and efficacy profiles and support…”
    Get full text
    Journal Article Book Review
  7. 7

    Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study by Francis-Sedlak, Megan, LaMoreaux, Brian, Padnick-Silver, Lissa, Holt, Robert J., Bello, Alfonso E.

    Published in Rheumatology and therapy. (01-03-2021)
    “…Introduction Gout is a common, progressive, systemic inflammatory arthritis caused by hyperuricemia. Current guidelines recommend that serum uric acid (sUA)…”
    Get full text
    Journal Article
  8. 8

    Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip by Tive, Leslie, Bello, Alfonso E, Radin, David, Schnitzer, Thomas J, Nguyen, Ha, Brown, Mark T, West, Christine R

    Published in Journal of pain research (01-01-2019)
    “…A pooled analysis was conducted to evaluate tanezumab efficacy and safety in patients with osteoarthritis (OA), including subgroup analyses of at-risk patients…”
    Get full text
    Journal Article
  9. 9

    DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug by Bello, Alfonso E.

    “…Chronic pain conditions affect at least 116 million US adults and more than one-third of adults worldwide. Nonsteroidal anti-inflammatory drugs (NSAIDs) are…”
    Get full text
    Book Review Journal Article
  10. 10

    Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritis by Whelton, Andrew, White, William B, Bello, Alfonso E, Puma, Joseph A, Fort, John G

    Published in The American journal of cardiology (01-11-2002)
    “…Concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs), including the cyclooxygenase-2 (COX-2) specific inhibitors, with antihypertensive medication…”
    Get full text
    Journal Article
  11. 11

    One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension by Bello, Alfonso E., Grahn, Amy Y., Ball, Julie, Kent, Jeffrey D., Holt, Robert J.

    Published in Current medical research and opinion (01-03-2015)
    “…Abstract Objective: To evaluate the safety of the fixed combination of ibuprofen and famotidine compared with ibuprofen alone from two 24-week, multicenter,…”
    Get full text
    Journal Article
  12. 12

    One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia by Bello, Alfonso E., Kent, Jeffrey D., Grahn, Amy Y., Ball, Julie, Holt, Robert J.

    Published in Current medical research and opinion (01-03-2015)
    “…Abstract Objective: To assess the long-term safety of the single-tablet combination of ibuprofen 800 mg and famotidine 26.6 mg. Research design and methods: A…”
    Get full text
    Journal Article
  13. 13

    Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons by Bello, Alfonso E, Kent, Jeffrey D, Holt, Robert J

    Published in The Physician and sportsmedicine (01-01-2015)
    “…A combination tablet of ibuprofen 800 mg and famotidine 26.6 mg given three times daily is effective for the treatment of rheumatoid arthritis and…”
    Get more information
    Journal Article
  14. 14

    Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients by Whelton, A, Fort, J G, Puma, J A, Normandin, D, Bello, A E, Verburg, K M

    Published in American journal of therapeutics (01-03-2001)
    “…Arthritis and hypertension are common comorbid conditions affecting elderly adults. Use of nonsteroidal anti-inflammatory drugs in patients treated with…”
    Get full text
    Journal Article
  15. 15

    Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib by Holt, Robert J, Fort, John G, Grahn, Amy Y, Kent, Jeffrey D, Bello, Alfonso E

    Published in The Physician and sportsmedicine (01-01-2015)
    “…To further characterize time-to-first pain relief, effect size, correlations between various outcome measures and durability of relief for single-tablet…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: Pooled analysis of 2 trials by GOLDSTEIN, Jay L, BELLO, Alfonso E, SPALDING, William, SUH, Sandy, FORT, John G

    Published in Journal of rheumatology (2005)
    “…To evaluate the relative gastrointestinal (GI) tolerability of celecoxib and rofecoxib in elderly hypertensive patients with osteoarthritis (OA) with or…”
    Get full text
    Journal Article
  19. 19

    COX-2 Specific Inhibitors in the Management of Osteoarthritis of the Knee: A Placebo-Controlled, Randomized, Double-Blind Study by McKenna, Frank, Weaver, Arthur, Fiechtner, Justus J, Bello, Alfonso E, Fort, John G

    Published in Journal of clinical rheumatology (01-06-2001)
    “…COX-2 specific inhibitors have demonstrated significant safety advantages and comparable efficacy in osteoarthritis (OA) compared with conventional…”
    Get full text
    Journal Article
  20. 20

    P-244: The effects of COX-2 specific inhibitors on edema and systolic blood pressure in elderly patients with osteoarthritis and treated hypertension: a pooled analysis on 1,902 patients by Puma, Joseph A., Bello, Alfonso E., Rodriguez, Jennifer J., Fort, John G.

    Published in American journal of hypertension (01-04-2002)
    “…Elderly patients with hypertension (HTN) and osteoarthritis (OA), who are already at high risk of cardiovascular events, may be particularly vulnerable to the…”
    Get full text
    Journal Article